Go Pro
→ This sub-5 dollar stock operates next to SpaceX and Blue Origin (From Freedom Financial) (Ad)tc pixel Free ONCSQ Stock Alerts

OncoSec Medical (ONCSQ) Competitors

Compare

ONCSQ vs. SXTPW, BFRIW, CINGW, CLVR, and CMRAW

Should you buy OncoSec Medical stock or one of its competitors? OncoSec Medical's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Cingulate (CINGW), Clever Leaves (CLVR), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does OncoSec Medical compare to 60 Degrees Pharmaceuticals?

OncoSec Medical (NASDAQ:ONCSQ) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations.

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than OncoSec Medical. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for OncoSec Medical. 60 Degrees Pharmaceuticals' average media sentiment score of 1.99 beat OncoSec Medical's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
OncoSec Medical Neutral
60 Degrees Pharmaceuticals Very Positive

60 Degrees Pharmaceuticals has higher revenue and earnings than OncoSec Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
OncoSec MedicalN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats OncoSec Medical on 3 of the 3 factors compared between the two stocks.

How does OncoSec Medical compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and OncoSec Medical (NASDAQ:ONCSQ) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
OncoSec Medical Neutral

Biofrontera has higher revenue and earnings than OncoSec Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$46.18MN/AN/AN/AN/A
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
OncoSec Medical N/A N/A N/A

Summary

Biofrontera beats OncoSec Medical on 1 of the 1 factors compared between the two stocks.

How does OncoSec Medical compare to Cingulate?

OncoSec Medical (NASDAQ:ONCSQ) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk, profitability and media sentiment.

Company Net Margins Return on Equity Return on Assets
OncoSec MedicalN/A N/A N/A
Cingulate N/A N/A N/A

In the previous week, OncoSec Medical's average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company Overall Sentiment
OncoSec Medical Neutral
Cingulate Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A
CingulateN/AN/AN/AN/AN/A

Summary

OncoSec Medical and Cingulate tied by winning 0 of the 0 factors compared between the two stocks.

How does OncoSec Medical compare to Clever Leaves?

OncoSec Medical (NASDAQ:ONCSQ) and Clever Leaves (NASDAQ:CLVR) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability.

OncoSec Medical has a beta of -30.04, meaning that its share price is 3,104% less volatile than the broader market. Comparatively, Clever Leaves has a beta of 3845.97, meaning that its share price is 384,497% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
OncoSec MedicalN/A N/A N/A
Clever Leaves N/A N/A N/A

Clever Leaves has higher revenue and earnings than OncoSec Medical. Clever Leaves is trading at a lower price-to-earnings ratio than OncoSec Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A
Clever Leaves$17.42M0.00-$17.90M-$9.66N/A

In the previous week, OncoSec Medical's average media sentiment score of 0.00 equaled Clever Leaves'average media sentiment score.

Company Overall Sentiment
OncoSec Medical Neutral
Clever Leaves Neutral

6.9% of Clever Leaves shares are held by institutional investors. 1.3% of OncoSec Medical shares are held by company insiders. Comparatively, 8.2% of Clever Leaves shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Clever Leaves beats OncoSec Medical on 5 of the 7 factors compared between the two stocks.

How does OncoSec Medical compare to Comera Life Sciences?

Comera Life Sciences (NASDAQ:CMRAW) and OncoSec Medical (NASDAQ:ONCSQ) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk, analyst recommendations and media sentiment.

In the previous week, Comera Life Sciences' average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score.

Company Overall Sentiment
Comera Life Sciences Neutral
OncoSec Medical Neutral

Company Net Margins Return on Equity Return on Assets
Comera Life SciencesN/A N/A N/A
OncoSec Medical N/A N/A N/A

Comera Life Sciences has higher revenue and earnings than OncoSec Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Comera Life Sciences$1.00MN/AN/AN/AN/A
OncoSec MedicalN/AN/A-$34.18M-$7.15N/A

Summary

Comera Life Sciences beats OncoSec Medical on 1 of the 1 factors compared between the two stocks.

Get OncoSec Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ONCSQ vs. The Competition

Export
MetricOncoSec MedicalPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$11.88B$7.06B$12.89B
Dividend YieldN/A2.59%2.54%9.14%
P/E Ratio0.00784.68271.7325.42
Price / SalesN/A756.28621.9393.08
Price / CashN/A15.1828.9235.62
Price / BookN/A11.0310.976.44
Net Income-$34.18M$2.81B$3.48B$358.18M

OncoSec Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ONCSQ
OncoSec Medical
N/AN/AN/AN/A$0.00N/AN/A40
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
-16.9%		N/A-50.7%$0.00$1.11MN/A2
BFRIW
Biofrontera
N/A$0.03
flat		N/A-80.0%$0.00$46.18MN/A70
CINGW
Cingulate
N/A$0.01
-22.0%		N/A-83.7%$0.00N/AN/A20
CLVR
Clever Leaves
N/A$0.00
flat		N/AN/A$0.00$17.42MN/A560

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:ONCSQ) was last updated on 9/8/2026 by MarketBeat.com Staff.
From Our Partners
2:59 PM Friday. I make this trade.
Tim Sykes says he books gains almost every weekend using one simple move. The trade is placed around 2:59 p...
Tim Sykes | Sponsoredtc pixel
Earth's biggest energy source: near Grand Canyon
The largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...
Behind the Markets | Sponsoredtc pixel
Forget SpaceX, Elon Is Now Powering the Next Hot IPO
Elon Musk is backing a new AI startup that's quietly growing faster than Tesla, SpaceX, and reportedly 23 time...
Brownstone Research | Sponsoredtc pixel
Congress Just Opened the Floodgates
The House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...
Awesomely | Sponsoredtc pixel
stop trying to pick stocks
Most traders think their problem is picking better stocks. It's actually time: holding losing positions too lo...
TradeWins | Sponsoredtc pixel
BlackRock and Vanguard already own THIS
Institutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 ...
Monument Traders Alliance | Sponsoredtc pixel
This looks like plywood. It's not.
AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...
Eagle Publishing | Sponsoredtc pixel
Musk says UBI is coming. I say it's already here.
Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...
Freedom Financial | Sponsoredtc pixel